The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of atezolizumab and bevacizumab combination therapy for patients with advanced hepatocellular carcinoma who previously received systemic treatment.
 
Takeshi Terashima
No Relationships to Disclose
 
Tatsuya Yamashita
Speakers' Bureau - Bayer; Chugai Pharma; Eisai; Lilly; Takeda
 
Makoto Yamamoto
No Relationships to Disclose
 
Masahiro Yanagi
No Relationships to Disclose
 
Hidetoshi Nakagawa
No Relationships to Disclose
 
Akihiro Seki
No Relationships to Disclose
 
Kouki Nio
No Relationships to Disclose
 
Kuniaki Arai
No Relationships to Disclose
 
Tadashi Toyama
No Relationships to Disclose
 
Taro Yamashita
Research Funding - Chugai Pharma